Literature DB >> 7904010

Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.

N A Buckley1, A H Dawson, I M Whyte, D A Henry.   

Abstract

Epidemiological studies have implicated dothiepin in a greater number of self-poisoning deaths than would be expected from its use. We have prospectively assessed the clinical toxicity of dothiepin and other tricyclic antidepressants (TCAs) in overdose. We followed-up consecutively admitted patients with TCA poisoning managed by our department between January, 1987, and August, 1992. 75 patients had taken dothiepin, 101 amitriptyline, 83 doxepin, and 61 other TCAs. Death after TCA poisoning is rare nowadays, so we used intermediate outcome measures--general seizures, tachyarrhythmias, sedation, and QRS width on the electrocardiogram. 15 patients had seizures and 7 tachyarrhythmias. When we excluded patients who had taken more than one TCA, general seizures were more likely after dothiepin than after other TCAs (9/67 vs 5/220) as were arrhythmias (4/67 vs 3/220). Rates of other complications were similar. The dothiepin group had ingested a larger dose, attributable to the larger average tablet strength, than patients who took other TCAs. The odds ratio for seizures with dothiepin versus other TCAs was 6.7 (95% Cl 2.2-20.7) unadjusted and 7.1 (2.2-23.2) after adjustment for sex, age, and ingested dose. The corresponding odds ratios for arrhythmias were 4.6 (1.0-21.1) and 3.4 (0.7-16.3). Dothiepin in overdose seems to be proconvulsant. Patients with only minor sedation and normal limb-lead QRS width may still have major complications. Consideration should be given to the use of other antidepressants in patients at risk of seizures or suicide. Regulatory authorities should review the need for a 75 mg strength tablet of any TCA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7904010     DOI: 10.1016/s0140-6736(94)90940-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

Review 1.  Tricyclic antidepressant overdose: a review.

Authors:  G W Kerr; A C McGuffie; S Wilkie
Journal:  Emerg Med J       Date:  2001-07       Impact factor: 2.740

2.  Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data?

Authors:  N A Buckley; P R McManus
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

3.  Antidepressants and suicide. Study analyses were flawed.

Authors:  I Whyte; N Buckley; G Carter
Journal:  BMJ       Date:  1995-07-01

4.  Suicide and antidepressants.

Authors:  J G Edwards
Journal:  BMJ       Date:  1995-01-28

Review 5.  Prevention of suicide: aspirations and evidence.

Authors:  D Gunnell; S Frankel
Journal:  BMJ       Date:  1994-05-07

6.  Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care.

Authors:  J Hippisley-Cox; M Pringle; V Hammersley; N Crown; A Wynn; A Meal; C Coupland
Journal:  BMJ       Date:  2001-09-22

7.  Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Authors:  Carlos Martinez; Themistocles L Assimes; Daniel Mines; Sophie Dell'aniello; Samy Suissa
Journal:  BMJ       Date:  2010-02-05

8.  Medical management of deliberate drug overdose: a neglected area for suicide prevention?

Authors:  D Gunnell; D Ho; V Murray
Journal:  Emerg Med J       Date:  2004-01       Impact factor: 2.740

Review 9.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

10.  [Intoxication with a tricyclic antidepressant].

Authors:  S G Sakka; F Kuethe; U Demme; E Hüttemann
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.